Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-06

Clinical Trial Update: A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial [NA]

View source ↗

Summary

A long-term safety study of the CyPass Micro-Stent in patients who completed the COMPASS trial has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CyPass Micro-Stent

Snippet

Sponsor: Alcon Research | Conditions: Primary Open Angle Glaucoma (POAG) | NA | Status: COMPLETED | Results posted: 2019-05-06